Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2708469012 | Parenteral form benztropine (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2774289013 | Parenteral form benztropine | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3487621014 | Product containing benzatropine in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496157012 | Product containing benzatropine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496158019 | Product containing benztropine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496159010 | Benztropine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496160017 | Benzatropine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3708756013 | Benztropine-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3708757016 | Benzatropine-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3708758014 | Product containing benzatropine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 105056101000001118 | Parenteral form benztropine | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing benzatropine in parenteral dose form (medicinal product form) | Is a | Product containing benzatropine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing benzatropine in parenteral dose form (medicinal product form) | Has active ingredient | Benzatropine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing benzatropine in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing benzatropine in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing benzatropine in parenteral dose form (medicinal product form) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Benztropine mesylate 2mg/2mL injection | Is a | False | Product containing benzatropine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only benzatropine in parenteral dose form (medicinal product form) | Is a | True | Product containing benzatropine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR